276 related articles for article (PubMed ID: 30726732)
41. The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells.
Odemis V; Lipfert J; Kraft R; Hajek P; Abraham G; Hattermann K; Mentlein R; Engele J
Glia; 2012 Mar; 60(3):372-81. PubMed ID: 22083878
[TBL] [Abstract][Full Text] [Related]
42. Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines.
Hanes MS; Salanga CL; Chowdry AB; Comerford I; McColl SR; Kufareva I; Handel TM
J Biol Chem; 2015 Sep; 290(37):22385-97. PubMed ID: 26216880
[TBL] [Abstract][Full Text] [Related]
43. Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.
Bach HH; Wong YM; Tripathi A; Nevins AM; Gamelli RL; Volkman BF; Byron KL; Majetschak M
Mol Med; 2014 Oct; 20(1):435-47. PubMed ID: 25032954
[TBL] [Abstract][Full Text] [Related]
44. Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.
Duval V; Alayrac P; Silvestre JS; Levoye A
Front Endocrinol (Lausanne); 2022; 13():906586. PubMed ID: 35846294
[TBL] [Abstract][Full Text] [Related]
45. Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.
Quinn KE; Mackie DI; Caron KM
Cytokine; 2018 Sep; 109():17-23. PubMed ID: 29903572
[TBL] [Abstract][Full Text] [Related]
46. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands.
Luker KE; Steele JM; Mihalko LA; Ray P; Luker GD
Oncogene; 2010 Aug; 29(32):4599-610. PubMed ID: 20531309
[TBL] [Abstract][Full Text] [Related]
47. Effects of Small Molecule Ligands on ACKR3 Receptors.
Hopkins BE; Masuho I; Ren D; Iyamu ID; Lv W; Malik N; Martemyanov KA; Schiltz GE; Miller RJ
Mol Pharmacol; 2022 Sep; 102(3):128-138. PubMed ID: 35809897
[TBL] [Abstract][Full Text] [Related]
48. Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting β-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis.
Yang J; Miao RR; Li YN; Pan T; Wu SH; Qu XJ; Cui SX
Acta Pharmacol Sin; 2022 Nov; 43(11):2967-2976. PubMed ID: 35365782
[TBL] [Abstract][Full Text] [Related]
49. Intermediate Progenitors Facilitate Intracortical Progression of Thalamocortical Axons and Interneurons through CXCL12 Chemokine Signaling.
Abe P; Molnár Z; Tzeng YS; Lai DM; Arnold SJ; Stumm R
J Neurosci; 2015 Sep; 35(38):13053-63. PubMed ID: 26400936
[TBL] [Abstract][Full Text] [Related]
50. Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.
Oishi S; Kuroyanagi T; Kubo T; Montpas N; Yoshikawa Y; Misu R; Kobayashi Y; Ohno H; Heveker N; Furuya T; Fujii N
J Med Chem; 2015 Jul; 58(13):5218-25. PubMed ID: 26042340
[TBL] [Abstract][Full Text] [Related]
51. Structural basis of ligand interaction with atypical chemokine receptor 3.
Gustavsson M; Wang L; van Gils N; Stephens BS; Zhang P; Schall TJ; Yang S; Abagyan R; Chance MR; Kufareva I; Handel TM
Nat Commun; 2017 Jan; 8():14135. PubMed ID: 28098154
[TBL] [Abstract][Full Text] [Related]
52. G Protein-Coupled Receptor Kinase 3 and Protein Kinase C Phosphorylate the Distal C-Terminal Tail of the Chemokine Receptor CXCR4 and Mediate Recruitment of
Luo J; Busillo JM; Stumm R; Benovic JL
Mol Pharmacol; 2017 Jun; 91(6):554-566. PubMed ID: 28331048
[TBL] [Abstract][Full Text] [Related]
53. β-arrestin control of late endosomal sorting facilitates decoy receptor function and chemokine gradient formation.
Mahabaleshwar H; Tarbashevich K; Nowak M; Brand M; Raz E
Development; 2012 Aug; 139(16):2897-902. PubMed ID: 22791893
[TBL] [Abstract][Full Text] [Related]
54. Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.
Szpakowska M; Nevins AM; Meyrath M; Rhainds D; D'huys T; Guité-Vinet F; Dupuis N; Gauthier PA; Counson M; Kleist A; St-Onge G; Hanson J; Schols D; Volkman BF; Heveker N; Chevigné A
Br J Pharmacol; 2018 May; 175(9):1419-1438. PubMed ID: 29272550
[TBL] [Abstract][Full Text] [Related]
55. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
[TBL] [Abstract][Full Text] [Related]
56. The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.
Wedemeyer MJ; Mahn SA; Getschman AE; Crawford KS; Peterson FC; Marchese A; McCorvy JD; Volkman BF
J Biol Chem; 2020 Oct; 295(40):13927-13939. PubMed ID: 32788219
[TBL] [Abstract][Full Text] [Related]
57. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.
Levoye A; Balabanian K; Baleux F; Bachelerie F; Lagane B
Blood; 2009 Jun; 113(24):6085-93. PubMed ID: 19380869
[TBL] [Abstract][Full Text] [Related]
58. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.
Struyf S; Noppen S; Loos T; Mortier A; Gouwy M; Verbeke H; Huskens D; Luangsay S; Parmentier M; Geboes K; Schols D; Van Damme J; Proost P
J Immunol; 2009 Jan; 182(1):666-74. PubMed ID: 19109200
[TBL] [Abstract][Full Text] [Related]
59. CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Chen Q; Zhang M; Li Y; Xu D; Wang Y; Song A; Zhu B; Huang Y; Zheng JC
Stem Cells; 2015 Aug; 33(8):2574-85. PubMed ID: 25833331
[TBL] [Abstract][Full Text] [Related]
60. Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.
Murphy PM; Heusinkveld L
Cytokine; 2018 Sep; 109():2-10. PubMed ID: 29398278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]